Dare Bioscience, Inc. Additional Paid in Capital, Common Stock
Dare Bioscience, Inc. (DARE) had Additional Paid in Capital, Common Stock of $191.95 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-03-26
- 2025-12-31: Additional Paid in Capital, Common Stock $191.95M.
- 2025-09-30: Additional Paid in Capital, Common Stock $190.50M.
- 2025-06-30: Additional Paid in Capital, Common Stock $171.35M.
- 2025-03-31: Additional Paid in Capital, Common Stock $170.52M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2025-12-31 | $191.95M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $190.50M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $171.35M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $170.52M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $169.71M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $168.66M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $168.14M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $167.38M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $166.55M 10-K · filed 2025-03-31 | $166.54M 10-K · filed 2024-03-28 |
| 2023-09-30 | $164.30M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $155.56M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $154.45M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $152.53M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $152.00M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $151.44M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $149.56M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $149.03M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $132.64M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $95.76M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $82.11M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $70.37M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $61.71M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $55.82M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $51.61M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $44.56M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $42.08M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $41.94M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $35.89M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $35.79M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $35.71M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $35.75M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $35.75M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $25.54M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $25.54M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $8.12K 8-K/A · filed 2017-10-02 | $215.21M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $214.76M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $17.12K 10-K · filed 2018-03-28 | $213.79M 10-K · filed 2017-03-31 |
| 2016-09-30 | $212.35M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $211.61M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $210.90M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $1.00 8-K/A · filed 2017-10-02 | $210.12M 10-K · filed 2016-03-10 |
| 2015-09-30 | $209.31M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $208.31M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $170.62M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $167.10M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |